AP
Healthcare & Life Sciences
Afferent Pharmaceuticals
United States
Afferent Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
series-c-plus
series-c-plus
Stage
2
Investors
About Afferent Pharmaceuticals
Afferent Pharmaceuticals is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Afferent Pharmaceuticals is a biopharmaceutical company focused on developing novel treatments, primarily targeting chronic pain and other substantial medical needs through a unique mechanism of action.
Explore Afferent Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.